Industry: Service & Software
Published Date: 2026-07-19
Pages: 120 Pages
Report ld: 6978674
Request Sample
Customized Report
CRISPR Screening Library Market Size(US$)

CAGR 2026-2032
15.0%
Market Size,2032
USD 583
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global CRISPR Screening Library market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 583 million by 2032 with a CAGR of 15.0% during the forecast period 2026-2032.
CRISPR screening libraries are high-throughput gene perturbation products comprising large sets of designed and quality-controlled guide RNA sequences supplied as vectors, viral particles, synthetic RNA, or other ready-to-use formats. They support gene knockout, interference, activation, or precision editing in cell populations, with phenotypic selection and sequencing used to identify key genes, pathways, and drug targets. Product value is mainly determined by target coverage, guide design quality, library uniformity, off-target control, delivery titer, and compatibility with downstream platforms. The blended gross margin is approximately 55%.
Demand for validated and reproducible functional-genomics evidence is rising across drug research, moving CRISPR screening libraries from specialist academic tools toward routine use in target discovery, mechanism studies, resistance analysis, and cell therapy engineering. Combined workflows that use genome-wide primary screens followed by focused validation screens are supporting growth in both catalog and custom libraries across oncology, immunology, metabolism, and rare-disease research.
Product development is expanding beyond conventional knockout libraries into CRISPR interference, CRISPR activation, base editing, and single-cell perturbation workflows. Suppliers increasingly compete on guide design algorithms, library uniformity, off-target control, viral titer, lot-level quality control, and compatibility with high-content imaging, cell sorting, and single-cell sequencing platforms. Integrated offerings that combine design, construction, packaging, and data analysis are becoming more important.
North America and Europe remain the main markets for premium products and pharmaceutical customers, while demand in China is being supported by innovative drug programs, cell therapy development, and expansion of research platforms. Key risks include cell-model-specific delivery performance, essential-gene bias, insufficient screen coverage, reproducibility, intellectual-property constraints, and biosafety requirements. Opportunities are concentrated in focused libraries, delivery to difficult cell models, single-cell-compatible libraries, and standardized analysis workflows.
The global CRISPR Screening Library market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the CRISPR Screening Library value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 CRISPR Knockout Libraries
1.2.3 CRISPR Interference Libraries
1.2.4 CRISPR Activation Libraries
1.2.5 Base Editing Libraries
1.2.6 Prime Editing Libraries
1.2.7 Other CRISPR Screening Libraries
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Drug Target Discovery and Validation
1.3.3 Drug Resistance and Sensitivity Screening
1.3.4 Synthetic Lethality and Combination Therapy
1.3.5 Functional Genomics and Pathway Analysis
1.3.6 Immuno-Oncology and Cell Therapy Engineering
1.3.7 Disease Modeling and Phenotype Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Screening Library Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global CRISPR Screening Library Market Share by Revenue, by Region (2021-2026)
2.4 Global CRISPR Screening Library Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.2 Europe CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.3 China CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.4 Japan CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.5 Southeast Asia CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.6 India CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.7 South America CRISPR Screening Library Market Size and Prospective (2021-2032)
2.5.8 Middle East CRISPR Screening Library Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global CRISPR Screening Library Historical Market Size by Type (2021-2026)
3.2 Global CRISPR Screening Library Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of CRISPR Screening Library
4 Breakdown Data by Application
4.1 Global CRISPR Screening Library Historical Market Size by Application (2021-2026)
4.2 Global CRISPR Screening Library Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in CRISPR Screening Library Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top CRISPR Screening Library Players by Revenue (2021-2026)
5.1.2 Global CRISPR Screening Library Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by CRISPR Screening Library Revenue
5.4 Global CRISPR Screening Library Market Concentration Analysis
5.4.1 Global CRISPR Screening Library Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by CRISPR Screening Library Revenue in 2025
5.5 Global Key Players of CRISPR Screening Library Head Offices and Areas Served
5.6 Global Key Players of CRISPR Screening Library, Product and Application
5.7 Global Key Players of CRISPR Screening Library, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America CRISPR Screening Library Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America CRISPR Screening Library Market Size by Type (2021-2026)
6.1.2.2 North America CRISPR Screening Library Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America CRISPR Screening Library Market Size by Application (2021-2026)
6.1.3.2 North America CRISPR Screening Library Market Share by Application (2021-2026)
6.1.4 North America CRISPR Screening Library Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe CRISPR Screening Library Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe CRISPR Screening Library Market Size by Type (2021-2026)
6.2.2.2 Europe CRISPR Screening Library Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe CRISPR Screening Library Market Size by Application (2021-2026)
6.2.3.2 Europe CRISPR Screening Library Market Share by Application (2021-2026)
6.2.4 Europe CRISPR Screening Library Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China CRISPR Screening Library Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China CRISPR Screening Library Market Size by Type (2021-2026)
6.3.2.2 China CRISPR Screening Library Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China CRISPR Screening Library Market Size by Application (2021-2026)
6.3.3.2 China CRISPR Screening Library Market Share by Application (2021-2026)
6.3.4 China CRISPR Screening Library Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan CRISPR Screening Library Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan CRISPR Screening Library Market Size by Type (2021-2026)
6.4.2.2 Japan CRISPR Screening Library Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan CRISPR Screening Library Market Size by Application (2021-2026)
6.4.3.2 Japan CRISPR Screening Library Market Share by Application (2021-2026)
6.4.4 Japan CRISPR Screening Library Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia CRISPR Screening Library Revenue by Company (2021-2026)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia CRISPR Screening Library Market Size by Type (2021-2026)
6.5.2.2 Southeast Asia CRISPR Screening Library Market Share by Type (2021-2026)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia CRISPR Screening Library Market Size by Application (2021-2026)
6.5.3.2 Southeast Asia CRISPR Screening Library Market Share by Application (2021-2026)
6.5.4 Southeast Asia CRISPR Screening Library Major Customers
6.5.5 Southeast Asia Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India CRISPR Screening Library Revenue by Company (2021-2026)
6.6.2 India Market Size by Type
6.6.2.1 India CRISPR Screening Library Market Size by Type (2021-2026)
6.6.2.2 India CRISPR Screening Library Market Share by Type (2021-2026)
6.6.3 India Market Size by Application
6.6.3.1 India CRISPR Screening Library Market Size by Application (2021-2026)
6.6.3.2 India CRISPR Screening Library Market Share by Application (2021-2026)
6.6.4 India CRISPR Screening Library Major Customers
6.6.5 India Market Trends and Opportunities
7 Key Player Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific CRISPR Screening Library Introduction
7.1.4 Thermo Fisher Scientific Revenue in CRISPR Screening Library Business (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck CRISPR Screening Library Introduction
7.2.4 Merck Revenue in CRISPR Screening Library Business (2021-2026)
7.2.5 Merck Recent Development
7.3 Revvity
7.3.1 Revvity Company Details
7.3.2 Revvity Business Overview
7.3.3 Revvity CRISPR Screening Library Introduction
7.3.4 Revvity Revenue in CRISPR Screening Library Business (2021-2026)
7.3.5 Revvity Recent Development
7.4 Integrated DNA Technologies
7.4.1 Integrated DNA Technologies Company Details
7.4.2 Integrated DNA Technologies Business Overview
7.4.3 Integrated DNA Technologies CRISPR Screening Library Introduction
7.4.4 Integrated DNA Technologies Revenue in CRISPR Screening Library Business (2021-2026)
7.4.5 Integrated DNA Technologies Recent Development
7.5 Synthego
7.5.1 Synthego Company Details
7.5.2 Synthego Business Overview
7.5.3 Synthego CRISPR Screening Library Introduction
7.5.4 Synthego Revenue in CRISPR Screening Library Business (2021-2026)
7.5.5 Synthego Recent Development
7.6 GenScript
7.6.1 GenScript Company Details
7.6.2 GenScript Business Overview
7.6.3 GenScript CRISPR Screening Library Introduction
7.6.4 GenScript Revenue in CRISPR Screening Library Business (2021-2026)
7.6.5 GenScript Recent Development
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Details
7.7.2 Agilent Technologies Business Overview
7.7.3 Agilent Technologies CRISPR Screening Library Introduction
7.7.4 Agilent Technologies Revenue in CRISPR Screening Library Business (2021-2026)
7.7.5 Agilent Technologies Recent Development
7.8 Twist Bioscience
7.8.1 Twist Bioscience Company Details
7.8.2 Twist Bioscience Business Overview
7.8.3 Twist Bioscience CRISPR Screening Library Introduction
7.8.4 Twist Bioscience Revenue in CRISPR Screening Library Business (2021-2026)
7.8.5 Twist Bioscience Recent Development
7.9 Cellecta
7.9.1 Cellecta Company Details
7.9.2 Cellecta Business Overview
7.9.3 Cellecta CRISPR Screening Library Introduction
7.9.4 Cellecta Revenue in CRISPR Screening Library Business (2021-2026)
7.9.5 Cellecta Recent Development
7.10 VectorBuilder
7.10.1 VectorBuilder Company Details
7.10.2 VectorBuilder Business Overview
7.10.3 VectorBuilder CRISPR Screening Library Introduction
7.10.4 VectorBuilder Revenue in CRISPR Screening Library Business (2021-2026)
7.10.5 VectorBuilder Recent Development
7.11 Ubigene
7.11.1 Ubigene Company Details
7.11.2 Ubigene Business Overview
7.11.3 Ubigene CRISPR Screening Library Introduction
7.11.4 Ubigene Revenue in CRISPR Screening Library Business (2021-2026)
7.11.5 Ubigene Recent Development
7.12 GeneCopoeia
7.12.1 GeneCopoeia Company Details
7.12.2 GeneCopoeia Business Overview
7.12.3 GeneCopoeia CRISPR Screening Library Introduction
7.12.4 GeneCopoeia Revenue in CRISPR Screening Library Business (2021-2026)
7.12.5 GeneCopoeia Recent Development
7.13 GeneChem
7.13.1 GeneChem Company Details
7.13.2 GeneChem Business Overview
7.13.3 GeneChem CRISPR Screening Library Introduction
7.13.4 GeneChem Revenue in CRISPR Screening Library Business (2021-2026)
7.13.5 GeneChem Recent Development
7.14 Applied Biological Materials
7.14.1 Applied Biological Materials Company Details
7.14.2 Applied Biological Materials Business Overview
7.14.3 Applied Biological Materials CRISPR Screening Library Introduction
7.14.4 Applied Biological Materials Revenue in CRISPR Screening Library Business (2021-2026)
7.14.5 Applied Biological Materials Recent Development
8 CRISPR Screening Library Market Dynamics
8.1 CRISPR Screening Library Industry Trends
8.2 CRISPR Screening Library Market Drivers
8.3 CRISPR Screening Library Market Challenges
8.4 CRISPR Screening Library Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for CRISPR Screening Library was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 583 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-07-19
Pages: 120
USD 3950.00
(Single User License)
The global CRISPR Screening Library market is projected to grow from US$ 218 million in 2025 to US$ 583 million by 2032, at a CAGR of 15.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-19
Pages: 135
USD 4900.00
(Single User License)
The global CRISPR Screening Library market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 583 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published Date: 2026-07-19
Pages: 112
USD 2900.00
(Single User License)
The global market for CRISPR Screening Library was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 583 million, growing at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-07-19
Pages: 120
The global CRISPR Screening Library market is projected to grow from US$ 218 million in 2025 to US$ 583 million by 2032, at a CAGR of 15.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-19
Pages: 135
The global CRISPR Screening Library market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 583 million by 2032, at a CAGR of 15.0% from 2026 to 2032.
Published: 2026-07-19
Pages: 112
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now